Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer

por Bašová, Petra, Pešta, Michal, Sochor, Marek, Stopka, Tomáš
Publicado 2017

Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents

por Bašová, Petra, Paszeková, Helena, Minařík, Lubomír, Dluhošová, Martina, Burda, Pavel, Stopka, Tomáš
Publicado 2022

Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

por Sochor, Marek, Basova, Petra, Pesta, Michal, Dusilkova, Nina, Bartos, Jiri, Burda, Pavel, Pospisil, Vit, Stopka, Tomas
Publicado 2014

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas

por Dusílková, Nina, Bašová, Petra, Polívka, Jindřich, Kodet, Ondřej, Kulvait, Vojtěch, Pešta, Michal, Trněný, Marek, Stopka, Tomáš
Publicado 2017